363 related articles for article (PubMed ID: 10976693)
1. A binary architectural grading system for uterine endometrial endometrioid carcinoma has superior reproducibility compared with FIGO grading and identifies subsets of advance-stage tumors with favorable and unfavorable prognosis.
Lax SF; Kurman RJ; Pizer ES; Wu L; Ronnett BM
Am J Surg Pathol; 2000 Sep; 24(9):1201-8. PubMed ID: 10976693
[TBL] [Abstract][Full Text] [Related]
2. The reproducibility of a binary tumor grading system for uterine endometrial endometrioid carcinoma, compared with FIGO system and nuclear grading.
Sagae S; Saito T; Satoh M; Ikeda T; Kimura S; Mori M; Sato N; Kudo R
Oncology; 2004; 67(5-6):344-50. PubMed ID: 15713989
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance and interobserver variability of histologic grading systems for endometrial carcinoma.
Scholten AN; Smit VT; Beerman H; van Putten WL; Creutzberg CL
Cancer; 2004 Feb; 100(4):764-72. PubMed ID: 14770433
[TBL] [Abstract][Full Text] [Related]
4. Description of a novel system for grading of endometrial carcinoma and comparison with existing grading systems.
Alkushi A; Abdul-Rahman ZH; Lim P; Schulzer M; Coldman A; Kalloger SE; Miller D; Gilks CB
Am J Surg Pathol; 2005 Mar; 29(3):295-304. PubMed ID: 15725797
[TBL] [Abstract][Full Text] [Related]
5. Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters.
Kapucuoglu N; Bulbul D; Tulunay G; Temel MA
Int J Gynecol Cancer; 2008; 18(4):790-6. PubMed ID: 17892460
[TBL] [Abstract][Full Text] [Related]
6. The reproducibility of histological parameters employed in the novel binary grading systems of endometrial cancer.
Gemer O; Uriev L; Voldarsky M; Gdalevich M; Ben-Dor D; Barak F; Anteby EY; Lavie O
Eur J Surg Oncol; 2009 Mar; 35(3):247-51. PubMed ID: 18775628
[TBL] [Abstract][Full Text] [Related]
7. Prognosis and reproducibility of new and existing binary grading systems for endometrial carcinoma compared to FIGO grading in hysterectomy specimens.
Guan H; Semaan A; Bandyopadhyay S; Arabi H; Feng J; Fathallah L; Pansare V; Qazi A; Abdul-Karim F; Morris RT; Munkarah AR; Ali-Fehmi R
Int J Gynecol Cancer; 2011 May; 21(4):654-60. PubMed ID: 21543931
[TBL] [Abstract][Full Text] [Related]
8. [Significance of prognostic evaluation of International Federation of Gynecology and Obstetrics 2009 staging system on stage I endometrioid adenocarcinoma].
Wang ZQ; Zhang Y; Wang JL; Shen DH; Mu T; Zhao X; Yao YY; Bai Y; Wei LH
Zhonghua Fu Chan Ke Za Zhi; 2012 Jan; 47(1):33-9. PubMed ID: 22455691
[TBL] [Abstract][Full Text] [Related]
9. Architectural versus nuclear atypia-defined FIGO grade 2 endometrial endometrioid adenocarcinoma (EEC): a clinicopathologic comparison of 154 cases with clinical follow-up.
Winham WM; Lin D; Stone PJ; Nucci MR; Quick CM
Int J Gynecol Pathol; 2014 Mar; 33(2):120-6. PubMed ID: 24487465
[TBL] [Abstract][Full Text] [Related]
10. Redefining stage I endometrial cancer: incorporating histology, a binary grading system, myometrial invasion, and lymph node assessment.
Barlin JN; Soslow RA; Lutz M; Zhou QC; St Clair CM; Leitao MM; Iasonos A; Hensley ML; Barakat RR; Matias-Guiu X; Abu-Rustum NR
Int J Gynecol Cancer; 2013 Nov; 23(9):1620-8. PubMed ID: 24126219
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the reproducibility of the revised 1988 International Federation of Gynecology and Obstetrics grading system of endometrial cancers with special emphasis on nuclear grading.
Nielsen AL; Thomsen HK; Nyholm HC
Cancer; 1991 Nov; 68(10):2303-9. PubMed ID: 1913466
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of nuclear grading and the revised FIGO grading of endometrial adenocarcinoma.
Ayhan A; Taskiran C; Yuce K; Kucukali T
Int J Gynecol Pathol; 2003 Jan; 22(1):71-4. PubMed ID: 12496701
[TBL] [Abstract][Full Text] [Related]
13. The comparison of the agreement in determining the histological grade of uterine endometrial endometrioid carcinoma, using the three-grade FIGO classification and the two-grade system.
Demczuk S; Wierzchowski W; SzczepaĆski W; Dyduch G; Czopek J; Stachura J
Pol J Pathol; 2003; 54(3):179-81. PubMed ID: 14703284
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of histological grade and vascular invasion compared with tumour cell proliferation in endometrial carcinoma of endometrioid type.
Stefansson IM; Salvesen HB; Immervoll H; Akslen LA
Histopathology; 2004 May; 44(5):472-9. PubMed ID: 15139995
[TBL] [Abstract][Full Text] [Related]
15. FIGO Versus Silverberg Grading Systems in Ovarian Endometrioid Carcinoma: A Comparative Prognostic Analysis.
Parra-Herran C; Bassiouny D; Vicus D; Olkhov-Mitsel E; Cesari M; Ismiil N; Nofech-Mozes S
Am J Surg Pathol; 2019 Feb; 43(2):161-167. PubMed ID: 30212391
[TBL] [Abstract][Full Text] [Related]
16. The Genomic Heterogeneity of FIGO Grade 3 Endometrioid Carcinoma Impacts Diagnostic Accuracy and Reproducibility.
Hussein YR; Broaddus R; Weigelt B; Levine DA; Soslow RA
Int J Gynecol Pathol; 2016 Jan; 35(1):16-24. PubMed ID: 26166718
[TBL] [Abstract][Full Text] [Related]
17. A Cell Type Independent Binary Grading System Does Not Significantly Improve Endometrial Biopsy Interpretation.
Nastic D; Kahlin F; Dahlstrand H; Carlson JW
Int J Gynecol Pathol; 2016 May; 35(3):256-63. PubMed ID: 26863477
[TBL] [Abstract][Full Text] [Related]
18. Endometrial Carcinoma Diagnosis: Use of FIGO Grading and Genomic Subcategories in Clinical Practice: Recommendations of the International Society of Gynecological Pathologists.
Soslow RA; Tornos C; Park KJ; Malpica A; Matias-Guiu X; Oliva E; Parkash V; Carlson J; McCluggage WG; Gilks CB
Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S64-S74. PubMed ID: 30550484
[TBL] [Abstract][Full Text] [Related]
19. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
[TBL] [Abstract][Full Text] [Related]
20. [Survival, prognostic factors and modern tendencies in adjuvant treatment of diagnosed endometrial cancer patients with or without lymph node dissection].
Ivanov I
Akush Ginekol (Sofiia); 2009; 48 Suppl 1():3-11. PubMed ID: 20387272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]